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Summary The Syrian hamster embryo cell lines, SHOK and MC-1, were used as recipient cells for DNA
transfection assay to detect transforming genes in experimental mouse tumours. A mouse repeat sequence was
utilised to check whether each transformed focus included mouse genomic DNA in the Hamster background.
We investigated five mouse tumours that are related to X-ray radiation, and detected activated c-K-ras, c-mos,
and c-cot oncogenes which induced foci of hamster cells. These results show that SHOK and MC-1 cells have
unique properties for detecting transforming genes in experimental mouse tumours.
Development of the mouse NIH3T3 transfection assay has
led to the identification of several oncogenes in human
tumours and animal cells transformed by chemical car-
cinogens (Parada et al., 1982; Shimizu et al., 1983a; Sukumar
et al., 1983). Although the roles of such oncogenes in multi-
stage carcinogenesis are not fully understood, we are interest-
ed in detecting transforming genes involved in the mouse
tumours which are related to X-ray-radiation, to obtain some
insight about the role of murine oncogenes. In this experi-
mental system, the descendants of the irradiated mouse N5
strain tend to develop tumours and their susceptibility to
tumour formation is inherited as an autosomal dominant
trait as if it were induced by germ-line mutation (Nomura,
1982; 1983; 1986). It remains unknown, however, what kind
of genetic changes are involved in developing tumours in
these mice and whether activated oncogenes are actually
present in these tumours or not.
NIH3T3 cells are commonly used for detecting oncogenes
because of their high efficiency of transformation by
oncogenes. Since mouse-specific repeated DNA sequences do
not serve as molecular markers of foreign DNA in NIH3T3
cells, we have tried to find recipient cells of non-mouse
origin. Although there are other transfection systems using
non-mouse origin cells such as 4DH2 cells (Shiner et al.,
1988), their sensitivities against oncogenes are not as good as
NIH3T3. We developed the hamster SHOK and MC-1 cell
lines whose sensitivity against oncogenes is comparable to
NIH3T3 cells.
Here we report the novel properties of these hamster cells
as indicator cells for the focus-forming assay and detection of
the activated oncogenes in tumours formed in N5 mice
exposed to X-rays and cancer prone descendants whose
parents' germ line were irradiated with X-rays.
Materials and methods
Cell culture
Syrian hamster embryo fibroblast cell lines, SHOK and MC-
1 cells, were grown in Dulbecco's modified minimum essen-
tial medium (D-MEM) supplemented with 10% foetal calf
serum. NIH3T3 cells were grown in D-MEM supplemented
with 10% calf serum.
DNA transfection assay
High molecular weight DNAs extracted from mouse tumours
were transfected into NIH3T3, SHOK and MC-1 cells by the
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calcium phosphate coprecipitation method (Wigler, 1978).
After transfection, NIH3T3 cells were maintained in D-
MEM supplemented with 5% calf serum, SHOK and MC-1
cells were maintained in D-MEM supplemented with 3%
foetal calf serum. The foci were scored 21 days after transfec-
tion. DNA samples examined were as follows. Genomic
DNA: T24 for c-H-ras (Sukumar et al., 1983), HL-60 for
N-ras (Murray et al., 1983), CC-013 for c-K-ras (a NIH3T3
tranformant from colon cancer tissue; Sasai, unpublished
work). Cloned plasmid (Tsuchida et al., 1981), pEJras for
c-H-ras (Shih et al., 1982), pSV2neo-fgr for GR-FeSV
(Miyoshi et al., 1989), pZIPerbB for AEV (Aoki, unpublished
work), pSRA2 for RSV (DeLorbe et al., 1980), AFSV2 for
FSV (Shibuya et al., 1982), AAb3 for Abelson MLV (Goff et
al., 1980), pMSV-lL for Moloney-MSV (Beveren et al., 1981)
and pC60 for SSV (Gelmann et al., 1981).
Molecular hybridisation oftransforming genes
High molecular weight DNAs were digested with restriction
endonuclease and fractionated by electrophoresis in 0.7%
agarose gell (10fig DNA/lane) (Maniatis et al., 1982). Ten
micrograms of denatured total RNA were fractionated by
electrophoresis in 1.0% agarose formaldehyde gels (Perbal,
1988). DNA and RNA samples were transferred to a nylon
membrane filter and hybridised to the following probes:
p 014 (MIF/Bam/R/Bl superfamily sequence) for the mouse
repetitive sequence (Fujimoto et al., 1985), HindIII fragment
(880 bp) of Ha-MSV for Ha-ras (Hager et al., 1979), R-
fragment (1 kb) for N-ras (Shimizu et al., 1983b), HiHi 380
fragment for K-ras (Ellis et al., 1981), Ball-HindIII fragment
(790 bp) of Mo-MSV-HT-1 for mos (Vande Woude et al.,
1979) and EcoRI-HaeIII fragment (170 bp) of cot c-DNA
(Miyoshi et al., 1991). The DNA probes were labelled by the
multiprimer extension method to give 109c.p.m. iLg' DNA.
The filters were hybridised at 65°C over night in hybridisa-
tion buffer containing 6 x SSC, 5 x Denhardt, 0.1% SDS,
20fgml-' salmon sperm DNA. The filters were washed in
2 x SSC, 0.1% SDS at 65'C for 30 min, followed by washing
with 0.2 x SSC and 0.1% SDS for 10min. They were
exposed to an X-ray film at - 70°C with an intensifying
screen.
Results
New cell linesfor detecting murine oncogenes
We have established a hamster cell line SHOK (Syrian
Hamster Osaka, Kanazawa) from a GHE-L strain of Syrian
hamster embryo cells (Higashi et al., 1990). The GHE-L
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strain was shown to be tranformed by an activated c-H-ras
oncogene by Suzuki et al. but it was found to be transformed
less efficiently than NIH3T3 cells and to have a tendency to
generate spontaneous foci due to overgrowth. SHOK cells
were isolated as a subclone, which do not exhibit the disad-
vantages observed with GHE-L cells and were used for
focus-forming assay satisfactorily. The MC-1 (Myc-Clone-1)
cell line is one of the transfectants of the SHOK cell line
obtained with pSV2gpt-c-myc containing the second and
third exons of the mouse c-myc (Land et al., 1983) which was
expected to have higher transforming ability than the SHOK
cell line. Table I summarises the focus-forming ability of
various oncogenes in SHOK, MC-1 and NIH3T3 cells. All
recipient cells were transformed by tumour cellular DNAs
containing activated H-, N-, K-ras oncogenes. Typical
examples presented in Figure 1 indicate that spontaneous
overgrowth is a rare event in SHOK and MC-1 cell lines.
Both hamster cells were more sensitive than NIH3T3 cells to
N- and K-ras. HIowever, both SHOK and MC-1 cells showed
quite different properties from those of NIH3T3 cells with
regard to transformation by other viral oncogenes. Whereas
hamster cells were transformed less efficiently than NIH3T3
cells by v-fgr, v-erbB, v-src, v-fps and v-abl which are all
classified into tyrosine-specific protein kinases, they showed
about ten times higher efficiency than NIH3T3 cells to trans-
formation by v-mos, a serine/threonine-specific protein
kinase. Since the ability of incorporating foreign DNAs and
promoter/enhancer activity of viral LTRs were almost at
equal levels in all these cell lines (data not shown), these
differences in protein kinase-mediated transformation
efficiency between mouse and hamster cells might be att-
ributed to species-specific cellular factors which respond to
oncogenic function of the protein kinase family.
Although we obtained no significant differences between
the SHOK and MC-I cell lines, we used MC-I as well as
SHOK cells for further experiments as indicator cells in
transfection assays, because MC-I has a lower background of
overgrowth than SHOK cells.
TableI Transformingabilityofseveral oncogenesinNIH3T3, SHOK
and MC-I cells
Recipient cells
Donor DNA NIH3T3 SHOK MC-1
Genomic DNA'
T24 (c-H-ras) 16.0c 20.0 36.0
HL-60 (N-ras) 2.5 57.5 74.5
cc-013 (c-K-ras) 0.5 15.0 19.5
NIH3T3 (control) 0 0 0
Cloned DNAb
v-Ki-ras (Ki-MSV) 41.5 71.0 74.5
c-Ha-ras (pT24-ras) 65.5 200> 200>
v-fgr (GR-FeSV) 114.0 5.5 33.0
v-erbB (v-erbB + MLVLTR) 6.5 0 0
v-src (RSV) 28.0 0 0.5
v-fps (FSV) 23.5 2.5 16.5
v-abl (Ab-MLV) 21.5 0 0
v-mos (Mo-MSV) 4.0 51.0 47.0
v-sis (SSV) 6.0 0 0
control (carrier only) 0 0 0
aTenfLg cellular DNA was transfected into 100 mm dish seeded with
5 x I05 cells. bFifty ng plasmid orphage DNA with 10jig carrier DNA
was transfected into 60 mm dish seeded with 2 x 105 cells. CThe values
are the means for duplicate culture dishes (the number of foci/dish)
Table II Donor tumours used for DNA transfection assay
Tumour strain Generationa Histopathology
N5-2057 male parent Osteosarcoma
N5-BMX-2710 F3 Multiple undifferentiated tumourb
N5-BMX-3013 F3 Rhabdomyosarcoma
N5-BMX-2596 F2 Multiple undifferentiated tumourb
N5-BMX-2305 Fl Fibrosarcoma
aGeneration inwhich tumoursdeveloped.Fl to F3 aredescendantsof
the irradiated male mouse. bDifficult to specify the histological type
because of the undifferentiated morphology of the tumour cells.
Figure 1 Giemsa staining of SHOK, MC-I and NIH3T3 cells transfected by the activated c-H-ras gene (T24-ras). a and d, MC-I
cells; b and e, SHOK cells; c and f, NIH3T3 cells. The upper dishes a, b and c contain several transformed foci and the lower
dishes d, e and f are mock-transfected negative controls. Cells were fixed in ethanol and stained with Giemsa solution 21 days after
transfection.264 H. SASAI et al.
Figure 2 Phase-contrast microphotographs ( x 10) of SHOK and MC-1 cell colonies transformed by DNA extracted from
X-ray-induced heritable and non-heritable mouse tumours. a, SHOK (negative control); b, SHOK transformed by the activated
c-H-ras (T24-ras); c, SHOK 2057 f-i; d, MC-1 2057 f-14; e, SHOK 3013 f-I; f, SHOK 2710 f-i.
Transfection ofmouse tumour DNAs into hamster cells
As shown in Table II, cellular DNAs were obtained from
transplantable tumours derived from a non-heritable tumour
formed in the male N5 mouse irradiated with 504 rad of
X-rays (Nomura, 1986) and four heritable tumours formed in
the Fl to F3 cancer prone descendants. We transfected
tumour DNAs into three recipient cells and scored the
number of transformed foci (Table III). In primary transfec-
tion, DNAs extracted from a non-heritable tumour N5-2057
and two heritable tumours, N5-BMX-2710 and N5-BMX-
3013, showed transforming ability in SHOK and MC-1 cells
(Figure 2). The N5-BMX-2710 tumour DNA scored one
focus in NIH3T3 cells as well. DNAs extracted from the
primary foci were confirmed to induce transformation of all
the recipient cells examined in the second cycle of transfec-
tion. The other two heritable tumours, N5-BMX-2305 and
N5-BMX-2596, were both negative in primary and secondary
transfections.
Detection oftransforming genes
DNA extracted from hamster cells transformed by transfec-
tion of mouse tumour DNAs were analysed for the presence
of the mouse repetitive sequence using Southern blots probed
with p 014. All primary transformants except for SHOK
2710 f-I were found to have mouse repetitive sequences
(Figure 3). Although SHOK 2710 f-I derived from the
heritable tumour did not show a clear hybridisation pattern,
its DNA was confirmed to induce transformed foci in the
secondary and tertiary transfection. These results suggest that
mouse repetitive DNA sequences were not closely associated
with the location of the responsible transforming gene in
SHOK 2710 f-i.
We then analysed whether DNAs of these three transfor-
mants contained additional bands of mouse origin which
might be homologous to several known oncogene sequences
under the background of hamster cellular DNA. We found
that SHOK 2057 f-1, the transformant from the X-ray-
induced osteosarcoma showed an extra band (about 12 kb
EcoRI fragment) which hybridised to mos (Figure 4a). In
contrast, other transformants induced by the same tumour
DNA, MC-1 2057 f-i and 12 clearly had 16 kb, 3.7 kb and
1.6 kb HindIII fragments which hybridised to the K-ras
probe (Figure 4b). These additional bands homologous to the
mouse c-K-ras gene were also found in the other three MC-1
transformants derived from N5-2057 (data not shown).
Northern blot analysis of the mos transformant (SHOK 2057
f-1) shows that mos is expressed at high levels (Figure 5) and
further analysis of genomic structure of mos gene in this
transformant shows that the small part of N-terminal coding
region of this gene was replaced with a hamster genomic
Table III DNA transfection assay on SHOK, MC-I and NIH3T3
Recipient cells
Donor DNA NIH3T3 SHOK MC-I
Primary transfectiona
N5-2057 0/340 iLg 1/310fig 5/90 Lg
N5-BMX-2710 1/280gig 1/420gAg 0/90 lg
N5-BMX-3013 0/220lag 1/220fig 0/90fig
N5-BMX-2596 3/280 iLg 0/380gig 0/90gig
N5-BMX-2305 0/310gLg 0/160gig NDb
Secondary transfectionc
N5-2057
SHOK 2057 f-i 111/45gig 129/45 gig ND
MC-1 2057 f-ll ND 57/100fig ND
MC-1 2057 f-12 ND 79/100 gig ND
N5-BMX-2710
NIH 2710 f-I 8/430gig 2/90gig ND
SHOK 2710 f-I ND ND 4/60 gig
N5-BMX-3013
SHOK 3013 f-i 6/90gig 43/60gig ND
N5-BMX-2596
NIH 2596 f-I ND 0/190fig ND
NIH 2596 f-2 0/60gig 0/300 gig ND
NIH 2596 f-3 0/340lgg 0/175 gig ND
Tertiary transfection
N5-2057
SHOK 2057 f-i-i 9/60gig >200/60gig >200/60gig
MC-1 2057 f-11-1 12/90 gig ND ND
N5-BMX-2710
SHOK 2710 f-1-4 ND 81/60 ig 81/60 g
aTotalcellularDNAsextractedfrom tumoursoftheN5mouseandits
progeny were transfected and scored by number of foci perglg donor
DNA. bNot determined. cDNAs were extracted from primary
transformants and transfected into mouse or hamster recipient cells.SYRIAN HAMSTER CELL LINES AS INDICATORS 265
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Figure 3 Detection of mouse repetitive sequences in SHOK and MC-1 cells transformed by X-ray-induced mouse tumour DNAs.
Total cellular DNAs extracted from transformed cells were digested with EcoRI, electrophoresed in 0.7% agarose gel, transferred
to a nylon membrane and hybridised with 4.8 kb HindIII fragment of p 014 containing the mouse repetitive sequence. Lane 1,
SHOK; lane 2 to 8, SHOK and MC-1 primary transformants. (lane 2, SHOK 2057 f-i; lane 3 to 6, MC-1 2057 f-lI to f-14; lane 7,
SHOK 2710 f-l; lane 8 SHOK 3013 f-1).
sequence which has strong promoter activity (Ouchi et al.,
1992). Therefore this activation of the mos gene was probably
generated artificially during the step of transfection.
As for the two hamster transformants obtained from
heritable mouse tumour DNAs, probes of the ras family
failed to hybridise to any exogenous restriction fragments of
both SHOK 2710 f-I and SHOK 3013 f-i. While we did not
perform further characterisation of the 'non ras' tranforming
gene in SHOK 2710 f-i, the other transformant SHOK 3013
a
1 2 3
f-I was found by molecular hybridisation to contain the cot
oncogene, a member of serine-specific protein kinases, which
we have recently isolated from human thyroid cancer using
the SHOK transfection assay (Miyoshi et al., 1991). Figure
4c shows that the approximately 4 kb EcoRI fragment, which
hybridised to the cot probe and corresponded in size to the
endogenous mouse cot restriction fragment, was present in
the SHOK 3013 f-I transformant (lane 3).
b
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Figure 4 Analysis of mos, K-ras and cot sequence in the DNAs of SHOK and MC-1 cells transformed by X-ray-induced tumour
DNAs. Ten micrograms of each DNA was digested with EcoRI a and c or HindIll b, electrophoresed in 0.7% agarose gel,
transferred to a nylon membrane and hybridised with the following probes: a, the 0.79 kb BalI-HindIII fragment of v-mos; b, the
HiHi 380 fragment of v-K-ras, and c, the EcoRI-HaeIII fragment of cot c-DNA. a, Lane 1, mouse NIH3T3 DNA; lane 2, hamster
SHOK DNA; and lane 3, SHOK 2057 f-I DNA. b, Lane 1, mouse NIH3T3 DNA; lane 2, hamster SHOK DNA; and lane 3 to 4,
MC-1 2057 f- II to 12 DNAs. c, Lane 1, mouse NIH3T3 DNA; lane 2, hamster SHOK DNA; and lane 3, SHOK 3013 f-I DNA.266 H. SASAI et al.
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Figure 5 Expression of the mos oncogene in SHOK 2057 f-I
cells. Ten micrograms of total RNAs prepared from cultured cells
were electrophoresed, transferred to a nylon membrane and
hybridised with the mos probe. Lane 1, SHOK RNA; lane 2,
SHOK 2057 f-i RNA. The triangles indicate the positions of 28S
and 18S rRNA.
In brief, we have identified three murine oncogenes, K-ras,
mos and cot, in experimental mouse tumour DNAs which
induced transformed foci of hamster cells. Detection of
serine/threonine-specific protein kinases such as mos and cot
also reconfirms the observation that SHOK and MG-i cells
were preferentially transformed by v-mos. These results seem
to provide molecular evidence for the practical utility of
hamster SHOK and MG-i cells to detect and characterise
murine oncogenes.
Discussion
The hamster cell lines SHOK and MG-I seem to have some
advantages as indicator cells for detecting oncogenes. First,
they are more useful tools than NIH3T3 cells to analyse
mouse tumour DNAs since the mouse repetitive DNA
sequence serves as a molecular marker to detect and isolate
transforming DNA sequences. Although mice and hamsters
are closely related rodents, we have shown that the mouse
tumour DNAs are clearly distinguished from hamster cellular
DNA by Southern hybridisation probing the cloned mouse
repetitive seqeunce. Second, their differential sensitivities to
transformation by a variety of oncogenes open up the pos-
sibility to detect new classes of oncogenes which have not
been identified by the NIH3T3 transfection assay. The novel
cot oncogene encoding a serine-specific protein kinase was
actually detected in human thyroid carcinoma (Miyoshi et
al., 1991) and colon cancer tissue DNA (Sasai et al., in
preparation) using SHOK cells. The murine cot and mos were
also identified in this study. These findings indicate that
SHOK and MC-1 cells are highly susceptible to oncogenes of
the serine/threonine-specific protein kinase family. Third,
their growth behaviour and low frequency in developing
spontaneous overgrowth were ideal properties for screening
oncogenes. We have estimated that their transformation
efficiency was much greater than that of Rat 1, Rat 2 of
Swiss 3T3, and comparable to that of NIH3T3 and
C3HIOTl/2 cells (data not shown).
In the osteosarcoma N5-2057 formed in the irradiated
parent mouse, the c-K-ras oncogene was detected. We
presume the activation of c-K-ras would be correlated with
X-ray-induced carcinogenesis since a similar case has been
reported in a X-ray-induced mouse thymic lymphoma (Guer-
rero et al., 1984).
The activation of the mos oncogene in SHOK 2057 f-i,
which is due to promoter insertion during the step of trans-
fection, has similarity with the case of a murine plastocytoma
which has the insertion of intercisternal A-particle serving as
a strong promoter in mos gene (Canaani et al., 1984).
Although we have detected cot and an unidentified 'non-
ras' oncogene in two offour heritable tumours, it is presently
unknown whether they have been activated by germ-line
mutations. Since we have only one primary transformant in
each of these cases, it is possible that activation of these
oncogene are due to the artifact of transfection. The charac-
terisation of the transformant (SHOK 3013 f-i) should be
done using the mouse c-DNA of c-cot gene which has
recently been cloned.
Negative results in detecting the ras gene family during the
survey using SHOK, MC-I and NIH3T3 cells suggest that
the ras oncogenes may not be frequently involved in develop-
ment of these X-ray-induced heritable tumours.
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